GlaxoSmithKline reported 6.42B in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 9518M 611M
Alcon AG ALC:SW 1.88B 100M
Amgen AMGN:US $ 5.7B 1.93B
AstraZeneca AZN:LN 7.09B 1.67B
Bayer BAYN:GR 13.14B 3.89B
Biogen BIIB:US $ 2289.3M 569.2M
Bristol Myers Squibb BMY:US $ 9.99B 666M
Eli Lilly And LLY:US $ 5336.7M 313.6M
Fresenius FRE:GR 8.22B 247M
Fresenius Medical Care FME:GR 3.9B 160M
Galapagos GLPG:NA 199.82M 24.86M
Genmab GEN:DC 1.18B 136M
Gilead Sciences GILD:US $ 3971M 438M
GlaxoSmithKline GSK:LN 6.42B 692M
Glaxosmithkline GSK:US 6.42B 692M
GRIFOLS GRF:SM 1.1B 129.52M
H. Lundbeck A/S LUN:DC 3.36B 27M
Hikma Pharmaceutical HIK:LN 873M 27M
Lonza Group LONN:SW 2.22B 1.07B
Merck MRK:GR 3.82B 233M
Merk MRK:US $ 9905M 839M
Novartis NOVN:VX 9.82B 464M
Orion ORNBV:FH 183.9M 9.8M
Pfizer PFE:US $ 13063M 3998M
Philips PHIA:NA € 4145M 266M
Recordati REC:IM 260.52M 565K
Regeneron Pharmaceuticals REGN:US $ 1791.3M 375.3M